A Study of Oraxol® in Gastric Cancer Patients

Clinical trial NCT01491217 · UNKNOWN

Trial details

NCT number: NCT01491217
Sponsor: Hanmi Pharmaceutical Company Limited
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Metastatic Gastric Cancer Recurrent Gastric Cancer

Start date: 2009-05-01
Primary completion: 2012-03-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.